How does the Prostate Cancer iPRS™ determine a person’s risk?

The test analyzes millions of DNA markers associated with prostate cancer and integrates this with clinical information such as age, ancestry, and family history. This comprehensive approach helps generate a detailed risk estimate that can inform screening and prevention strategies.

The test has been validated across diverse populations to provide more reliable risk predictions for individuals of varying ancestries.